Can Cerebrolysin improve cognition in healthy people, or is its evidence limited to neurological conditions?

It would be inaccurate to say Cerebrolysin has never been studied in healthy people. A 1998 randomized study enrolled 48 healthy men and examined brain electrical activity and short-term memory during ten days of treatment, including a hyperventilation challenge used as an experimental stress model. It reported EEG changes and some memory trends, not persuasive evidence of lasting improvements in everyday cognition. The highest exposure also produced mild adverse effects and a small reduction in blood pressure. An EEG change is not itself a measure of improved intelligence or productivity.[1]

Other human trials have studied neurological illness, including Alzheimer’s disease. A treatment signal in an impaired population cannot establish enhancement in a healthy person with a different baseline and risk-benefit balance. To support routine cognitive use, we would need larger, replicated trials measuring meaningful everyday outcomes and longer-term safety. The existing small volunteer experiment does not answer whether repeated courses help healthy people work, learn or remember better over months or years. It supports further investigation, not a reliable promise of a “brain reset.”[1][2]